These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17238194)

  • 21. Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.
    Deng R; Balthasar JP
    Blood; 2007 Mar; 109(6):2470-6. PubMed ID: 17132715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR; Lazarus AH
    Semin Hematol; 2016 Apr; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
    Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR
    Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
    Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
    Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
    Crow AR; Yu H; Han D; Lazarus AH
    PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS; Sun DS; Lien TS; Chang HH
    Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
    Neschadim A; Branch DR
    Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection.
    Dimaano EM; Saito M; Honda S; Miranda EA; Alonzo MT; Valerio MD; Mapua CA; Inoue S; Kumaori A; Matias R; Natividad FF; Oishi K
    Am J Trop Med Hyg; 2007 Dec; 77(6):1135-8. PubMed ID: 18165536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody.
    Abuqayyas L; Zhang X; Balthasar JP
    Int J Pharm; 2013 Feb; 444(1-2):185-92. PubMed ID: 23370434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia.
    Schmugge M; Franzoso FD; Winkler J; Kroiss S; Seiler M; Speer O; Rand ML
    Br J Haematol; 2023 Jun; 201(6):1209-1219. PubMed ID: 36861460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia.
    Kapur R; Aslam R; Kim M; Guo L; Ni H; Segel GB; Semple JW
    Platelets; 2017 Jul; 28(5):521-524. PubMed ID: 27885866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia and other immune thrombocytopenias: lessons from mouse models.
    McKenzie SE; Reilly MP
    Semin Thromb Hemost; 2004 Oct; 30(5):559-68. PubMed ID: 15497098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.
    Tremblay T; Aubin E; Lemieux R; Bazin R
    Br J Haematol; 2007 Oct; 139(2):297-302. PubMed ID: 17897306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
    Deng R; Balthasar JP
    Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.